This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Lupus Foundation Of America Recognizes Top Researchers With Prestigious Evelyn V. Hess Award And Mary Betty Stevens Prize

Dr. Ellen M. Ginzler Honored With Hess Award; Dr. Diane Leigh Kamen Receives Stevens Prize for Contributions to Lupus Research

WASHINGTON, Nov. 12, 2012 /PRNewswire-USNewswire/ -- The Lupus Foundation of America bestowed its top honors on two leading scientists for their exceptional achievements in lupus research, at its annual awards reception held tonight at the Newseum in Washington. Ellen M. Ginzler, M.D., M.P.H. was awarded the prestigious 2012 Evelyn V. Hess, M.D., M.A.C.P., M.A.C.R., Research Award, that the Lupus Foundation of America presents annually to a researcher who has made outstanding contributions to the field of lupus research, diagnosis, and treatment. Diane Leigh Kamen, M.D., M.S.C.R., was awarded the 2012  Mary Betty Stevens, M.D., Young Investigator Prize for her early contributions to the field.

(Logo: http://photos.prnewswire.com/prnh/20120711/DC38337LOGO)

The reception was hosted by the Lupus Foundation of America's National Board of Directors. Dr. Ginzler is the Division Chief of Rheumatology at the State University of New York's Downstate Medical Center while Dr. Kamen is an Assistant Professor of Medicine in the Division of Rheumatology at the Medical University of South Carolina (MUSC).

Dr. Ginzler is internationally known as an expert on lupus nephritis, which occurs when lupus causes inflammation in the kidneys, making them unable to properly remove waste from the blood or control the amount of fluids in the body.

As principal investigator of an Orphan Products Program grant awarded by the Food and Drug Administration to assess the efficacy and tolerability of two drug treatments for lupus nephritis, Dr. Ginzler headed the largest multicenter, investigator-initiated trial ever carried out at that time for lupus. The results, published as the lead article in the  New England Journal of Medicine in 2005 , have changed the paradigm for treating lupus nephritis. Dr. Ginzler is a Master of the American College of Rheumatology and a fellow of the American College of Physicians, and was a long-time member of the Board of Governors of the New York Chapter of the Arthritis Foundation.

The Lupus Foundation of America established the annual Hess award in 2005 to honor Dr. Hess for her outstanding contributions to lupus research over the course of her long career. The award is given annually to a clinical or basic researcher whose body of work has advanced understanding of the pathophysiology, etiology, epidemiology, diagnosis, or treatment of lupus.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,076.27 +64.33 0.36%
S&P 500 2,114.07 +4.47 0.21%
NASDAQ 5,099.2310 +22.7070 0.45%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs